Table 9 | Cases of HIV Infection and AIDS in the United States, by Race/Ethnicity, 2000–2004 | Reports | Statistics and Surveillance | Topics

Home

About CDC

Press Room

A-Z Index

CDC en Español

CDC Home > HIV/AIDS > Topics > Statistics and Surveillance > Reports > Cases of HIV Infection and AIDS in the United States, by Race/Ethnicity, 2000–2004

Table 9. Estimated numbers of persons living with HIV infection (not AIDS), by race/ethnicity, sex, transmission category, and age category, 2001–2004—35 areas with confidential name-based HIV infection reporting

View PDF


Transmission category	2001	2002	2003	2004
	White, not Hispanic
Male adult or adolescent
Male-to-male sexual contact	38,419	41,283	43,726	46,608
Injection drug use	4,591	4,752	4,811	4,896
Male-to-male sexual contact and injection drug use	4,150	4,255	4,323	4,450
High-risk heterosexual contact^a	2,393	2,571	2,707	2,820
Other^b	459	458	454	450
Subtotal	50,011	53,320	56,022	59,224

Female adult or adolescent
Injection drug use	3,636	3,773	3,883	3,955
High-risk heterosexual contact^a	7,042	7,585	8,028	8,420
Other^b	153	159	156	154
Subtotal	10,832	11,516	12,067	12,529

Total adults and adolescents	60,843	64,836	68,089	71,753

Child (<13 yrs)
Perinatal	434	440	459	458
Other^c	159	146	138	133
Subtotal	593	586	597	591
Total	61,435	65,422	68,686	72,344

	Black, not Hispanic
Male adult or adolescent
Male-to-male sexual contact	24,764	26,934	28,772	30,842
Injection drug use	11,924	12,211	12,221	12,207
Male-to-male sexual contact and injection drug use	3,495	3,519	3,481	3,463
High-risk heterosexual contact^a	11,853	12,876	13,656	14,337
Other^b	397	398	403	402
Subtotal	52,433	55,937	58,533	61,251

Female adult or adolescent
Injection drug use	8,003	8,205	8,241	8,195
High-risk heterosexual contact^a	26,012	28,508	30,266	31,875
Other^b	488	516	545	553
Subtotal	34,503	37,229	39,052	40,623

Total adults and adolescents	86,935	93,166	97,585	101,874

Child (<13 yrs)
Perinatal	2,139	2,224	2,286	2,323
Other^c	335	349	349	363
Subtotal	2,473	2,573	2,635	2,686
Total	89,409	95,739	100,221	104,560

	Hispanic
Male adult or adolescent
Male-to-male sexual contact	9,440	10,848	12,072	13,425
Injection drug use	4,519	4,626	4,678	4,587
Male-to-male sexual contact and injection drug use	993	1,042	1,089	1,074
High-risk heterosexual contact ^a	2,531	2,847	3,126	3,356
Other^b	92	96	100	96
Subtotal	17,574	19,459	21,065	22,537

Female adult or adolescent
Injection drug use	1,997	2,066	2,070	2,007
High-risk heterosexual contact^a	4,853	5,389	5,725	5,965
Other^b	99	111	121	120
Subtotal	6,949	7,567	7,916	8,092

Total adults and adolescents	24,524	27,026	28,981	30,629

Child (<13 yrs)
Perinatal	733	757	768	788
Other^c	121	118	121	123
Subtotal	854	875	889	911
Total	25,378	27,901	29,870	31,540

	Asian/Pacific Islander
Male adult or adolescent
Male-to-male sexual contact	432	507	615	698
Injection drug use	76	89	92	93
Male-to-male sexual contact and injection drug use	21	24	30	36
High-risk heterosexual contact^a	82	105	121	134
Other^b	24	26	26	23
Subtotal	634	750	885	984

Female adult or adolescent
Injection drug use	32	37	45	50
High-risk heterosexual contact^a	165	197	223	259
Other^b	12	13	12	13
Subtotal	209	247	279	322

Child (<13 yrs)
Perinatal	13	16	18	18
Other^c	4	4	4	4
Subtotal	17	20	22	22
Total	860	1,018	1,186	1,328

	American Indian/Alaska Native
Male adult or adolescent
Male-to-male sexual contact	386	413	424	464
Injection drug use	94	94	96	95
Male-to-male sexual contact and injection drug use	91	91	95	89
High-risk heterosexual contact^a	47	56	62	73
Other^b	2	2	1	1
Subtotal	620	656	679	722

Female adult or adolescent
Injection drug use	80	90	96	96
High-risk heterosexual contact^a	146	167	186	201
Other^b	2	2	3	2
Subtotal	228	259	286	299

Total adults and adolescents	848	915	965	1,021

Child (<13 yrs)
Perinatal	8	10	10	10
Other^c	2	1	1	1
Subtotal	10	11	11	11
Total	858	926	976	1,032
Total cases^d	179,678	192,801	202,722	212,572

Note. These numbers do not represent reported case counts. Rather, these numbers are point estimates, which result from adjustments of reported case counts. The reported case counts are adjusted for reporting delays and for redistribution of cases in persons initially reported without an identified risk factor. The estimates do not include adjustment for incomplete reporting.

Since 2000, the following 35 areas have had laws or regulations requiring confidential name-based HIV infection reporting: Alabama, Alaska, Arizona, Arkansas, Colorado, Florida, Idaho, Indiana, Iowa, Kansas, Louisiana, Michigan, Minnesota, Mississippi, Missouri, Nebraska, Nevada, New Jersey, New Mexico, New York, North Carolina, North Dakota, Ohio, Oklahoma, South Carolina, South Dakota, Tennessee, Texas, Utah, Virginia, West Virginia, Wisconsin, Wyoming, Guam, and the U.S. Virgin Islands. Since July 1997, Florida has had confidential name-based HIV infection reporting for new diagnoses only.


^a	Includes heterosexual contact with a person who is HIV infected, a male who engages in male-to-male sex, a person who injects drugs, has hemophilia or coagulation disorder, or is a transplant or transfusion recipient.
^b	Includes hemophilia, blood transfusion, perinatal exposure, and risk factor not reported or not identified.
^c	Includes hemophilia, blood transfusion, and risk factor not reported or not identified.
^d	Includes persons of unknown race or multiple races and persons of unknown sex. Because column totals were calculated independently of the values for the subpopulations, the values in each column may not sum to the column total.

Last Modified: June 2, 2006
Last Reviewed: June 2, 2006
Content Source:
Divisions of HIV/AIDS Prevention
National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention

Home

Policies and Regulations

Disclaimer

e-Government

FOIA

Centers for Disease Control and Prevention, 1600 Clifton Rd, Atlanta, GA 30333, USA
800-CDC-INFO (800-232-4636) TTY: (888) 232-6348, 24 Hours/Every Day - cdcinfo@cdc.gov.

Department of Health
and Human Services